Xintian Pharmaceutical: Net profit of 9.1115 million yuan in 2025, down 82.59% year-on-year

2026-03-30 11:18:32

Xintian Pharmaceutical Industry announcement: In 2025, operating revenue was 750 million yuan, down 12.57% year over year. Net profit was 9.1115 million yuan, down 82.59% year over year. The profit distribution proposal approved by the company’s board of directors is as follows: cash dividends of 0.30 yuan per 10 shares to all shareholders (tax included), no bonus shares, and no capitalization of capital reserve to increase share capital.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.